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1. Introduction 
In previous studies, the relationship between aspartate aminotransferase to alanine 
aminotransferase ratio(AST/ALT ratio) and liver disease has been evaluated. In viral 
hepatitis, alcoholic liver disease and primary biliary cirrhosis, AST/ALT ratio has been 
proven to be an indicator of liver cirrhosis.1-3 AST/ALT ratio was a potential value in 
differentiating nonalcoholic steatohepatitis from alcoholic liver disease.The value < 1 
suggestted nonalcoholic steatohepatitis, a ratio of ≥ 2 was strongly suggestive of alcoholic 
liver disease.4 
Nonalcoholic fatty liver disease(NAFLD) is the most common cause of elevated liver 
enzymes and also one of the most common forms of liver disease in the world.5 The 
AST/ALT ratio of the ultrasound-diagnosed NAFLD patients was lower than controls.6 
AST/ALT ratio < 1 was common NAFLD-related feature.7 NAFLD is now considered the 
hepatic manifestation of the metabolic syndrome. When compared with individuals without 
NAFLD, individuals with NAFLD had significantly higher fasting glucose, insulin, low-
density lipoprotein cholesterol, triglycerides, systolic blood pressure and diastolic blood 
pressure.8 Recently, NAFLD marker the AST/ALT ratio have attracted great interest as 
potential novel marker of metabolic syndrome.9  
Very little information was available about the association of AST/ALT ratio with metabolic 
syndrome in Han young adults. Thus, this study evaluated the relationship between 
AST/ALT ratio and metabolic syndrome in Han young adults. 
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2. Materials and methods 
2.1 Subjects 
After obtaining the informed consent from all subjects, a cross-sectional, population-based 
study was conducted. The study population was determined according to 2-stage cluster 
sampling. In the first stage, a random sample of universities in Qinhuangdao, Hebei 
Province, China, were obtained; in the second stage, young adults aged 19 to 24 years, 
randomly selected from these schools, were invited to participate. In the end, 425 Han 
young adults(males/females 216/209) participated in 2009. Subjects with evidence of 
alcohol intake, hepatitis B (hepatitis B surface antigen), hepatitis C (hepatitis C antibody), 
autoimmune hepatitis (antinuclear antibody and anti-smooth muscle antibody) and drug 
toxicity were excluded. The study protocol was approved and supervised by the ethical 
committee of the First Hospital of Qinhuangdao. 
2.2 Measurements 
Anthropometric measurements, including height, weight and waist circumference(WC) 
were performed when subjects were without shoes and in light clothing. Height and weight 
were measured to the nearest 0.1 cm and 0.1 kg, respectively. Standing height without shoes 
was measured three times with a stadiometer, and the three measurements were averaged 
for analysis. Body mass index (BMI) was defined as weight (kg) divided by height (m) 
squared. Blood pressure was measured three times with a mercury sphygmomanometer 
while the subjects were seated after 10 min of rest, and the three measurements were 
averaged for analysis. 
After an overnight fast of 10–12h, blood samples were drawn from an antecubital vein in each 
subjects into vacutainer tubes. Fasting plasma glucose(FPG) concentration was measured 
using the glucose oxidase method, serum lipids and alanine aminotransferase (ALT) and 
aspartate alanine aminotransferase (AST) were measured using enzymatic procedures with an 
autoanalyzer (Hitachi, Tokyo, Japan). Serum true insulin(TI) was measured using enzyme 
linked immunosorbent assay(ELISA) with model 680 microplate reader(BIO-RAD, 
America).The ELISA kits were purchased from USCNLIFE company, America. The following 
equation for homeostasis model assessment of insulin resistance(HOMA-IR) was used: fasting 
insulin level (μU/ml) x fasting glucose level (mmol/l)/22.5.  
2.3 Definition for metabolic syndrome  
Metabolic syndrome was defined as having ≥3 of the 5 factors with the following cut points: 
abdominal obesity (waist circumference ≥90cm in males and 80 cm in females); high 
triglycerides(≥1.70mmol/L [150mg/dL]); low high density lipoprotein cholesterol (HDL-C) 
(<1.03 mmol/L[40mg/dL] for males and <1.30 mmol/L [50 mg/dL] for females); elevated 
blood pressure (systolic blood pressure≥135mmHg and/or diastolic blood 
pressure≥85mmHg) and impaired fasting glucose(≥5.6mmol/L[100mg/dL]).10 
2.4 Statistical analysis 
Data are expressed as mean ± standard deviation(SD) or medians with interquartile 
ranges(IQR).When data was not normally distributed, they were ln transformed for 
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analysis. Continuous variables were analyzed with covariance adjustment for age and sex. 
To measure the strength of association between 2 variables, partial correlation analysis was 
used adjustment for age and sex. The χ2 test was used to test for differences in proportions. 
To examine the association between AST/ALT ratio and metabolic syndrome, multivariate 
logistic regression was tested. The results of the logistic regression analysis were expressed 
as odds ratios with 95% confidence intervals(CI). Analyses were performed with the 
computer software SPSS version 11.5 software(SPSS Inc., Chicago, IL, U.S.A.). Statistical 
significance was established at P<0.05.  
3. Results 
3.1 Clinical and laboratory characteristics 
In this sample, AST/ALT ratio < 1 was detected in 146 subjects (34.4%). Males had a 
significantly higher frequency of AST/ALT ratio < 1 than females(48.6% vs 19.6%,χ2 = 
39.595,P=0.000). The age was similar in two groups(20.3±0.8 vs 20.3±0.8, t=0.057,P=0.955). 
Table 1 showed clinical and laboratory characteristics in the study subjects. After 
adjustment for age and sex, young adults with AST/ALT ratio < 1 had higher BMI, WC, 
SBP, DBP, TG, TI and HOMA-IR than subjects with AST/ALT ratio ≥ 1. Subjects with 
AST/ALT ratio < 1 also had significantly lower HDL-C than subjects with AST/ALT ratio 
≥ 1 (P<0.05). The level of FPG was similar between subjects with AST/ALT ratio < 1 and ≥ 
1 (P>0.05).(Table 1)  
Associations of AST/ALT ratio with anthropometric and metabolic variables were 
presented in Table 2. After adjustment for age and sex, AST/ALT ratio showed positive 
correlations with HDL-C and negative correlations with BMI, WC, TG，TI and HOMA-IR 
(P<0.05). (Table 2)  
3.2 AST/ALT ratio and metabolic syndrome 
The prevalence of metabolic syndrome was 2.1% and was similar in males and females(2.3% 
vs 1.9%,χ2 = 0.082,P= 0.774). Subjects with AST/ALT ratio < 1 had a significantly higher 
frequency of abdominal obesity, high triglycerides, elevated blood pressure and metabolic 
syndrome(P<0.05). (Table 3) After adjustment for age, sex and BMI, the frequency of 
metabolic syndrome among young adults with AST/ALT ratio < 1 was 6.975(95%CI: 1.430 
to 34.019, P=0.016) times compared with young adults with AST/ALT ratio ≥ 1. 
4. Discussion 
Using Adult Treatment Panel III criteria's definition, we estimated that approximately 2.1% 
of Han young adults have the metabolic syndrome. The prevalence of metabolic syndrome 
in this study was lower than previously report from Chinese adults and was similar to 
Chinese adolescents.11,12 It was because of a positive effect of age on the prevalence of 
metabolic syndrome.13,14 Abdominal obesity, elevated blood pressure and low HDL-C were 
common components of the metabolic syndrome in this sample. In the insulin resistance 
atherosclerosis study, NAFLD marker the AST/ALT ratio predict metabolic syndrome 
independently of potential confounding variables.15 In this study, we found that the 
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metabolic syndrome was related with a lower AST/ALT ratio in Han young adults. Subjects 
with AST/ALT ratio < 1 had a significantly higher frequency of abdominal obesity, high 
triglycerides, elevated blood pressure and metabolic syndrome. The association was not 
modified by age, sex and BMI. 
 
variable 
AST/ALT level ratio≥1 
(n=279) 
AST/ALT level ratio< 1 
(n=146) 
P 
Age(years) mean(SD) 20.3(0.8) 20.3(0.8) 0.955 
Sex(male/female) 111/168 105/41 0.000 
BMI(kg/m2) mean(SD) 22.9(3.8) 26.3(4.0) 0.000 
WC(cm) mean(SD) 70.8(9.3) 81.4(12.3) 0.000 
SBP(mmHg) mean(SD) 109.3(10.7) 115.2(11.5) 0.004 
DBP(mmHg) mean (SD) 73.1(8.2) 76.7(9.9) 0.030 
FPG(mmol/L) mean (SD) 4.30(0.44) 4.38(0.40) 0.101 
TG(mmol/L) mean (SD) 0.69(0.24) 0.83(0.46) 0.000 
HDL-C(mmol/L) mean (SD) 1.42(0.22) 1.30(0.24) 0.001 
TI( uU/ml) median (IQR) 6.58(3.88) 7.75(4.86) 0.014 
HOMA-IR median(IQR) 1.25(0.76) 1.53(1.08) 0.006 
ALT(U/L) mean(SD) 10.6(5.0) 30.6(17.3) 0.000 
AST(U/L) mean(SD) 17.9(6.0) 20.6(8.5) 0.223 
 
Data are expressed as mean ± standard deviation(SD) or medians with interquartile ranges(IQR). 
Continuous variables were analyzed with covariance adjustment for age and sex. When data was not 
normally distributed, they were ln transformed for analysis. ALT: alanine aminotransferase; AST: 
aspartate aminotransferase; BMI: body mass index; WC: waist circumference; SBP: systolic blood press; 
DBP: diastolic blood press; FPG: fasting plasma glucose; TG: triglycerides; HDL-C: high density 
lipoprotein cholesterol; TI: true insulin; HOMA-IR: homeostasis model assessment of insulin resistance; 
SD: standard deviation; IQR:indicates interquartile range. 
Table 1. Clinical and laboratory characteristics of the subjects in different levels of AST/ALT 
ratio. 
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variable r P* r P** 
BMI(kg/m2) -0.296 0.000 -0.281 0.000 
WC(cm) -0.310 0.000 -0.264 0.000 
SBP(mmHg) -0.141 0.004 -0.072 0.134 
DBP(mmHg) -0.102 0.036 -0.048 0.321 
FPG(mmol/L) -0.051 0.295 -0.039 0.413 
TG(mmol/L) -0.134 0.006 -0.134 0.006 
HDL-C(mmol/L) 0.174 0.000 0.125 0.010 
TI( uU/ml) -0.154 0.001 -0.118 0.015 
HOMA-IR -0.158 0.001 -0.121 0.012 
*Pearson correlation.**Partial correlation analysis, adjustment for age and sex. ALT: alanine 
aminotransferase; AST: aspartate aminotransferase; BMI: body mass index; WC: waist circumference; 
SBP: systolic blood press; DBP: diastolic blood press; FPG: fasting plasma glucose; TG: triglycerides; 
HDL-C: high density lipoprotein cholesterol; TI: true insulin; HOMA-IR: homeostasis model assessment 
of insulin resistance. 
Table 2 Correlation analysis of AST/ALT ratio with anthropometric and metabolic variables 
in Han young aduts. 
 
Factor 
AST/ALT level ratio≥1 
(n=279) 
AST/ALT level ratio< 1 
(n=146) 
P 
abdominal obesity(%) 9.7 32.2 0.000 
high triglycerides(%) 0.0 3.4 0.008 
low high density lipoprotein 
cholesterol(%) 
15.1 21.2 0.109 
elevated blood pressure(%) 12.9 25.3 0.001 
impaired fasting glucose(%) 0.7 0.0 0.548 
metabolic syndrome(%) 0.7 4.8 0.016 
The χ2 test was used to test for differences in proportions. ALT: alanine aminotransferase; AST: 
aspartate aminotransferase. 
Table 3 Prevalence of metabolic syndrome in different levels of AST/ALT ratio(%). 
www.intechopen.com
 
Recent Advances in Cardiovascular Risk Factors 
 
252 
In our study, AST/ALT ratio showed negative correlation with HOMA-IR. Insulin 
resistance is a central feature in the pathogenesis of metabolic syndrome,while insulin 
resistance is now considered the main link between metabolic disturbances and liver 
enzymes. Hanley AJ et al.16 reported that AST/ALT ratio was associated with directly 
measured insulin sensitivity when conventionally availables were adjusted. This result can 
be explained by the following possible mechanism. Liver markers were known to be 
significantly correlated with increased hepatic fat content.17 Liver fat content was a 
significant risk factor of HOMA-IR while BMI and waist circumference were not.18  
In our study, we found that young adults with AST/ALT ratio < 1 had higher TI than 
subjects with AST/ALT ratio ≥ 1. But the level of FPG was similar between subjects with 
AST/ALT ratio < 1 and ≥ 1. The liver plays an important role in maintaining normal glucose 
concentrations during fasting as well as postprandially. The loss of a direct effect of insulin 
to suppress hepatic glucose production and glycogenolysis in the liver causes an increase in 
hepatic glucose production.19 Increased insulin levels with increasing insulin resistance in 
subjects with AST/ALT ratio < 1 suggested that elevated insulin concentrations reflected 
increased beta cell output to the elevated insulin concentrations. The hyperinsulinemia can 
thus be seen as a compensatory mechanism for the preexisting insulin resistance, which 
represents a mechanism for protection against the development of impaired fasting glucose 
and diabetes. T2DM will result when there is insufficient insulin secretion to counter 
preexisting insulin resistance.20 
Diet habit modifies the relationship of the liver enzymes ratio with metabolic syndrome. For 
example, Mediterranean diet moderates the association of the liver enzymes ratio with the 
prevalence of the metabolic syndrome.9 In China, people's eating habits are quite different in 
different area. Regrettably, diet habit was not evaluated in our study. This is a limitation of 
our study. 
In conclusion, the prevalence of metabolic syndrome was low in Han young adults. 
AST/ALT ratio was related with metabolic syndrome in Han young adults.  
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